Learn more about whether AstraZeneca PLC or Jazz Pharmaceuticals plc is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Learn more about whether AstraZeneca PLC or Corcept Therapeutics Incorporated is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...
Q4 2024 Earnings Conference Call March 31, 2025 4:30 PM ETCompany ParticipantsAdanna Alexander – IRPhillip Chan - ...
Xponance Inc. raised its position in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 6.9% during the fourth quarter, ...
For this article, we used a Finviz screener to filter all the available ADR stocks. Then we compare the list with our Q4 2024 ...
Hosted on MSN14d
Forget the Correction: This Stock Is Defying the Sell-Off, and There Might Be More Upside AheadThe second is for Brilinta, a treatment used to reduce the risk of heart attacks. Neither of these patent expirations should be a game changer for AstraZeneca. Soliris' sales in 2024 totaled $2.6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback